Discovery and Development of Triptans - History

History

Search for a new anti-migraine drug started at Glaxo in 1972. Studies in the 1960s showed that vasoconstriction from 5-HT, ergotamine and noradrenaline could reduce migraine attacks. Research also showed that platelet 5-HT level is reduced during migraine. Because there are too many side-effects for 5-HT to be used as a drug, scientists started research on the receptors of 5-HT in order to discover and develop a more specific agonist for 5-HT receptors. Research on the 5-HT receptors and their effect led to discovery of several types and subtypes of 5-HT. AH24167 showed a vasodilation effect instead of vasoconstriction due to the agonist effect on another type of 5-HT receptors later assigned the name 5-HT7. AH25086 was the second compound developed and showed a vasoconstriction effect but was not released as a drug due to low per oral bioavailability. Continued research led to the discovery of the first triptan drug, sumatriptan, that had both vasoconstriction effect, as well as better oral bioavailability. Sumatriptan was first launched in Holland in 1991 and became available in the USA during 1993.

Read more about this topic:  Discovery And Development Of Triptans

Famous quotes containing the word history:

    Perhaps universal history is the history of the diverse intonation of some metaphors.
    Jorge Luis Borges (1899–1986)

    They are a sort of post-house,where the Fates
    Change horses, making history change its tune,
    Then spur away o’er empires and o’er states,
    Leaving at last not much besides chronology,
    Excepting the post-obits of theology.
    George Gordon Noel Byron (1788–1824)

    History ... is, indeed, little more than the register of the crimes, follies, and misfortunes of mankind.
    But what experience and history teach is this—that peoples and governments have never learned anything from history, or acted on principles deduced from it.
    Georg Wilhelm Friedrich Hegel (1770–1831)